How Do You Manage Fatigue During Cancer Treatment?

Cancer Care · Fatigue & Energy
Cancer-related fatigue is not the same as being tired after a long day. It doesn’t get better with rest. It doesn’t respond to coffee. And it affects up to 80 percent of people undergoing cancer treatment — making it the most commonly reported and most disruptive side effect of the entire treatment experience. (1)
Understanding what’s driving it is the first step toward managing it.
What Causes Cancer-Related Fatigue
Cancer-related fatigue is multifactorial. It can stem from the disease itself, the treatment, or both — and several biological mechanisms are typically involved simultaneously:
Anemia. Chemotherapy suppresses bone marrow, reducing red blood cell production. Fewer red blood cells means less oxygen delivery to muscles and the brain — a direct cause of profound physical and cognitive fatigue. (2)
Inflammatory cytokines. Cancer and its treatments trigger the release of pro-inflammatory cytokines including IL-6 and TNF-alpha. These molecules directly affect the central nervous system, producing fatigue, cognitive slowing, and a general sense of malaise that researchers call “sickness behavior.” (3)
Mitochondrial dysfunction. Chemotherapy agents can damage mitochondria — the energy-producing organelles in every cell. When mitochondria are impaired, cellular energy production falls even when oxygen and nutrients are available. (4)
Nutritional deficiencies. Nausea, reduced appetite, and impaired absorption during treatment commonly lead to deficiencies in B12, iron, magnesium, and other nutrients essential for energy metabolism. (5)
Sleep disruption. Pain, anxiety, steroids, and treatment schedules all interfere with sleep architecture. Poor sleep compounds every other cause of fatigue.
What the Evidence Says About Managing It
The most important first step is assessment. Fatigue can have correctable causes — anemia, thyroid dysfunction, depression, nutritional deficiency — that require specific treatment. A conversation with your oncologist about fatigue levels, including standardized screening, is essential before pursuing management strategies.
Beyond that, the interventions with the strongest evidence include:
Exercise. This is counterintuitive for people who feel exhausted, but it is the single most evidence-backed intervention for cancer-related fatigue. A 2019 systematic review and meta-analysis found that both aerobic exercise and resistance training significantly reduced fatigue during and after cancer treatment across multiple cancer types. (6) Even moderate walking — 20 to 30 minutes most days — produces measurable benefit.
Sleep hygiene. Consistent sleep and wake times, limiting stimulants, and addressing pain or anxiety that disrupt sleep can meaningfully improve fatigue levels. Cognitive behavioral therapy for insomnia (CBT-I) has shown benefit in cancer populations specifically.
Nutritional optimization. Addressing specific deficiencies — particularly B12, iron, and magnesium — with the guidance of your care team can restore the raw materials needed for energy metabolism. Adequate protein intake supports muscle preservation and energy availability throughout the day.
Mind-body practices. Mindfulness-based stress reduction, yoga, and acupuncture all have moderate evidence supporting their role in reducing cancer-related fatigue and improving quality of life during treatment. (7)
Evidence-Backed Fatigue Management Strategies
- Moderate aerobic exercise and resistance training (strongest evidence)
- Consistent sleep schedule and CBT-I if needed
- Correction of nutritional deficiencies (B12, iron, magnesium)
- Adequate protein and hydration throughout the day
- Mind-body practices: mindfulness, yoga, acupuncture
- Screening and treatment for anemia, depression, thyroid dysfunction
What About Supplements for Fatigue?
Several nutritional compounds have a mechanistic basis for supporting cellular energy production — particularly those that target mitochondrial function.
Vitamin B12 is essential for neurological function, red blood cell formation, and DNA synthesis. Deficiency — common in cancer patients due to reduced absorption and poor appetite — is a direct and correctable cause of fatigue. Methylated B12 (methylcobalamin) is the most bioavailable form.
PQQ (pyrroloquinoline quinone) supports mitochondrial biogenesis — the production of new mitochondria. Research suggests PQQ supplementation improves markers of mitochondrial function and energy metabolism. (8)
Acetyl-L-Carnitine plays a direct role in transporting fatty acids into mitochondria for energy production. Clinical trials have examined its potential to reduce chemotherapy-induced fatigue and neuropathy, with some positive signals in the literature. (9)
As always: discuss any supplement with your oncologist before adding it during active treatment.
The Bottom Line
Cancer-related fatigue is real, it’s biological, and it’s manageable — but it requires a targeted approach. Exercise remains the most evidence-backed intervention. Nutritional assessment and correction of deficiencies addresses correctable root causes. And supporting mitochondrial function with the right compounds can help restore cellular energy from the inside out.

Supplements / Cellular Energy
Elevated Energy — Mitochondrial Energy Support
Formulated by TWC’s Chief Medical Board, Elevated Energy combines Methylated B12, PQQ, Acetyl-L-Carnitine, L-Tyrosine, and Theacrine to support clean, sustained cellular energy — targeting mitochondrial function at its core, without stimulants or a crash.
Shop NowYou Might Also Be Interested In
References
- Bower, J. E. (2014). Cancer-related fatigue: Mechanisms, risk factors, and treatments. Nature Reviews Clinical Oncology, 11(10), 597–609.
- Cella, D., et al. (2004). The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients. Annals of Oncology, 15(6), 979–986.
- Dantzer, R., et al. (2012). Translational approaches to treatment-induced symptoms in cancer patients. Nature Reviews Clinical Oncology, 9(7), 414–426.
- Conley, K. E., et al. (2016). Mitochondrial dysfunction in cancer. Cancer & Metabolism, 4(1), 3.
- Arends, J., et al. (2017). ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition, 36(1), 11–48.
- Hilfiker, R., et al. (2018). Exercise and other non-pharmaceutical interventions for cancer-related fatigue. British Journal of Sports Medicine, 52(10), 651–658.
- Bower, J. E., & Lamkin, D. M. (2013). Inflammation and cancer-related fatigue. Brain, Behavior, and Immunity, 30(Suppl), S48–S57.
- Harris, C. B., et al. (2013). Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. Journal of Nutritional Biochemistry, 24(12), 2076–2084.
- Cruciani, R. A., et al. (2006). L-carnitine supplementation for the management of fatigue in patients with advanced cancer. Journal of Pain and Symptom Management, 32(6), 551–559.
Author
This article is for informational purposes only and does not constitute medical advice. Always consult your oncologist or a qualified healthcare provider before starting any supplement regimen during cancer treatment.





